Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$446K Sell
7,272
-6
-0.1% -$367 0.01% 320
2026
Q1
$505K Sell
7,278
-5,027
-41% -$387K 0.02% 293
2025
Q4
$936K Sell
12,305
-9,325
-43% -$749K 0.03% 226
2025
Q3
$1.86M Sell
21,630
-2,303
-10% -$174K 0.06% 166
2025
Q2
$1.63M Sell
23,933
-375
-2% -$23.2K 0.06% 174
2025
Q1
$1.45M Sell
24,308
-298
-1% -$18.9K 0.05% 185
2024
Q4
$1.49M Buy
+24,606
New +$1.51M 0.06% 173
2022
Q2
Sell
-1,819
Closed -$218K 452
2022
Q1
$218K Hold
1,819
0.01% 428
2021
Q4
$300K Buy
1,819
+395
+28% +$65.9K 0.01% 380
2021
Q3
$212K Buy
+1,424
New +$222K 0.01% 431

Other funds holding APTV

Ingalls & Snyder LLC's APTV Position: Q2 2026 in Review

Ingalls & Snyder LLC reduced its Aptiv (APTV) stake by 0.08% in Q2 2026, selling an estimated $367 and leaving 7,272 shares worth $446K. The position accounts for 0.01% of the portfolio, ranked #320.

Ingalls & Snyder LLC first reported a position in APTV in Q3 2021 and has held it in 10 quarters since. The position peaked at $1.86M in Q3 2025. 661 funds tracked by Wall St. Rank hold APTV as of Q2 2026.

  • Ingalls & Snyder LLC held 7,272 shares of Aptiv worth $446K as of Q2 2026.
  • Ingalls & Snyder LLC sold 6 Aptiv shares in Q2 2026, an estimated $367.
  • Aptiv made up 0.01% of Ingalls & Snyder LLC's portfolio in Q2 2026, its #320 holding.
  • Ingalls & Snyder LLC first reported a position in Aptiv in Q3 2021 and has held it in 10 quarters since.
  • Ingalls & Snyder LLC's Aptiv position peaked at $1.86M in Q3 2025.
  • 661 funds tracked by Wall St. Rank held Aptiv as of Q2 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2026, filed 14 Aug 2026.